Research
Education
Healthcare
Community
About
Mar 23, 2022 | UC Irvine School of Medicine
UCI-led study reveals how TREM2 gene mutation in brain microglia immune cells can increase Alzheimer’s risk
Findings show blocking excess calcium accumulation may be effective therapy.
Mar 02, 2022
Rachel Sousa: 1st place in the UCI Grad Slam 2022. “Curing Cancer with Math”
Feb 17, 2022 | UC Irvine News
Physiology & biophysics professor co-writes book on how membranes, their proteins work
Stephen H. White, a professor of physiology & biophysics in the UCI School of Medicine since 1973, has co-authored a book that he calls the culmination of his career.
Jan 26, 2022 | ABC10 News San Diego
In-Depth: How a scientist laid the groundwork for the mRNA COVID vaccines in San Diego
Dr. Philip Felgner's contributions to mRNA vaccine technology were highlighted by ABC10 San Diego.
Jan 10, 2022 | UC Irvine School of Medicine
UCI-led team first to discover new neural circuits that regulate spatial learning and memory in the brain’s hippocampal formation
Understanding of novel functional roles can advance research in Alzheimer’s disease, other learning and memory disorders
Nov 19, 2021 | Graduate Studies
2021 Carlin Fellows
Congratulations to the 2021 Carlin Fellows!
Nov 15, 2021 | UC Irvine School of Medicine
UCI-led study finds single molecule within a specific plant used by Native Americans can treat both pain and diarrhea
Nov 09, 2021 | UC Irvine School of Medicine
UCI researchers reveal critical role of mechanosensor in skin wound healing
PIEZO1, an ion channel mechanosensor found within cells, has been revealed to play a key role in regulating the speed of skin wound healing.
Nov 08, 2021 | UC Irvine School of Medicine
UCI Center for Neural Circuit Mapping Investigators receive funding from three federal awards for a total of more than $7M
The University of California, Irvine Center for Neural Circuit Mapping (CNCM) has been awarded three new grants.
Oct 22, 2021 | UC Irvine School of Medicine
UCI-led study suggests new molecular target for therapeutic interventions aimed at C. difficile infection
A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead to new treatments to fight this deadly disease.